DOI: 10.1055/s-00000054

Pharmacopsychiatry

Ausgabe 02 · Volume 50 · März 2017 DOI: 10.1055/s-007-33576

Review

  • 49
    Colle, R.; de Larminat, D.; Rotenberg, S.; Hozer, F.; Hardy, P.; Verstuyft, C.; Fève, B.; Corruble, E.:

    PPAR-γ Agonists for the Treatment of Major Depression: A Review

    • Original Paper

  • 56
    Novick, Diego; Montgomery, William; Treuer, Tamas; Moneta, Maria Victoria; Haro, Josep Maria:

    Real-world Effectiveness of Antipsychotics for the Treatment of Negative Symptoms in Patients with Schizophrenia with Predominantly Negative Symptoms

    • Original Paper

  • 64
    Kashani, L.; Eslatmanesh, S.; Saedi, N.; Niroomand, N.; Ebrahimi, M.; Hosseinian, M.; Foroughifar, T.; Salimi, S.; Akhondzadeh, S.:

    Comparison of Saffron versus Fluoxetine in Treatment of Mild to Moderate Postpartum Depression: A Double-Blind, Randomized Clinical Trial

    • Original Paper

  • 69
    Takeuchi, T.; Takenoshita, S.; Taka, F.; Nakao, M.; Nomura, K.:

    The Relationship between Psychotropic Drug Use and Suicidal Behavior in Japan: Japanese Adverse Drug Event Report

  • 74
    Fujioi, J.; Iwamoto, K.; Banno, M.; Kikuchi, T.; Aleksic, B.; Ozaki, N.:

    Effect of Adjunctive Aripiprazole on Sexual Dysfunction in Schizophrenia: A Preliminary Open-Label Study